Advanced in Midline Lethal Granuloma

Pierre Duffau

Bordeaux, FR 
Advanced in Midline Lethal Granuloma
Bordeaux, FR 
OverviewLocationsClinical Research

Overview

Pierre Duffau practices in Bordeaux, France. Mr. Duffau is rated as an Advanced expert by MediFind in the treatment of Midline Lethal Granuloma. His top areas of expertise are Neurosarcoidosis, Systemic Lupus Erythematosus (SLE), Systemic Sclerosis (SSc), Scleroderma, and Splenectomy.

His clinical research consists of co-authoring 122 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Midline Lethal Granuloma.

Gender
Male

Locations

Bordeaux, France
Other Locations
Pessac-sur-dordogne, 33604, France
1 Rue Jean Burguet, Saint-jean-saint-germain, 33000, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

Soluble CD95 Ligand Role in the Pathophysiology of ANCA Associated Vasculitis
Soluble CD95 Ligand Role in the Pathophysiology of ANCA Associated Vasculitis
Enrollment Status: Completed
Publish Date: May 28, 2025
Intervention Type: Biological
Study Phase: Not Applicable
Involvement of Immune Cells Derived From the Intestine in Sjogren's Syndrome
Involvement of Immune Cells Derived From the Intestine in Sjogren's Syndrome
Enrollment Status: Completed
Publish Date: February 21, 2025
Intervention Type: Biological
Study Drugs: Blood sample, Biopsy of the labial salivary gland
Study Phase: Not Applicable
O-GlcNAcylation Role in the Pathophysiology of Systemic Lupus Erythematosus
O-GlcNAcylation Role in the Pathophysiology of Systemic Lupus Erythematosus
Enrollment Status: Completed
Publish Date: January 19, 2024
Intervention Type: Biological
Study Phase: Not Applicable
Microparticles's Role in the Pathophysiology of Systemic Lupus Erythematosus and Systemic Sclerosis
Microparticles's Role in the Pathophysiology of Systemic Lupus Erythematosus and Systemic Sclerosis
Enrollment Status: Completed
Publish Date: March 08, 2023
Intervention Type: Biological
Study Phase: Not Applicable
Study of the Efficacy of Propranolol for the Management of Epistaxis in Hereditary Hemorrhagic Telangiectasia Patients
Study of the Efficacy of Propranolol for the Management of Epistaxis in Hereditary Hemorrhagic Telangiectasia Patients
Enrollment Status: Completed
Publish Date: June 14, 2022
Intervention Type: Drug
Study Drug: Propranolol
Study Phase: Phase 3
Anemil Trial : Phase I/II Clinical Trial Evaluating the Interest of Interleukine-2 for Patients With Active Warm Hemolytic Anemia Resistant to Conventional Treatment
Anemil Trial : Phase I/II Clinical Trial Evaluating the Interest of Interleukine-2 for Patients With Active Warm Hemolytic Anemia Resistant to Conventional Treatment
Enrollment Status: Completed
Publish Date: February 18, 2019
Intervention Type: Drug
Study Phase: Phase 1/Phase 2
Pilot Study Related to the Effect of Clopidogrel on Plasmatic Soluble CD40 Ligand During Systemic Lupus Erythematous
Pilot Study Related to the Effect of Clopidogrel on Plasmatic Soluble CD40 Ligand During Systemic Lupus Erythematous
Enrollment Status: Completed
Publish Date: October 25, 2017
Intervention Type: Drug
Study Phase: Phase 1/Phase 2
View 6 Less Clinical Trials

122 Total Publications

Rituximab Versus Conventional Therapy for Remission Induction in Eosinophilic Granulomatosis With Polyangiitis : A Randomized Controlled Trial.
Rituximab Versus Conventional Therapy for Remission Induction in Eosinophilic Granulomatosis With Polyangiitis : A Randomized Controlled Trial.
Journal: Annals of internal medicine
Published: July 28, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Duffau's expertise for a condition
ConditionClose
    View All 11 Advanced Conditions
    View All 45 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile